SARD-ILD
Cross-source consensus on SARD-ILD from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Other
Other
Other
Highlighted claims
- The study cohort included 6,431 patients with SARD-ILD and evidence of ILD progression. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
- SARD-ILD is interstitial lung disease occurring in people with systemic autoimmune rheumatic diseases. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
- The study described treatments, symptoms, and healthcare use after ILD progression in SARD-ILD patients. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
- SARD-ILD can progress and is associated with substantial morbidity and mortality. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study